EXCLUSIVE: Ketamine Therapy Provider Nushama Co-Founder On Shifting From A Consciousness Of Blame Into A Space Of Responsibility
In light of the latest news regarding the DEA’s telehealth regulations and the
Reported Late Tuesday March 14, ICZOOM Group Inc. Announces Pricing Of $6M Initial Public Offering Of 1.5M Shares Of Stock At A Price Of $4/Share; Expected To Commence Trading On March 15, 2023 Under The Ticker Symbol “IZM”
ICZOOM Group Inc. (the "Company" or "ICZOOM"), a B2B e-commerce trading platform primarily engaged in sales of electronic component products in Hong Kong and mainland China, today
OKYO Pharma Limited Prices $5.3M Offering Of 3,503,665 ADSs At A Price Of $1.50/ADS
OKYO Pharma Limited (NASDAQ:OKYO) (LSE: OKYO) (“OKYO Pharma” or the “Company“), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory
Adamis Pharmaceuticals Announces $3M Registered Direct Offering With A Single, Healthcare-Focused Institutional Investor
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including opioid overdose,
OKYO Pharma Announces $5.74M Private Placement And Investment By Directors, Senior Management Members
OKYO will issue 3,503,665 new ADSs (representing 227,738,225 new Ordinary Shares) ("New ADSs") to certain investors at a price of U.S.$1.50 per New ADS ("U.S. Offering Price") raising gross